trial
as of 2026-07-01Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCTId NCT03872596
at a glance
Phase 1 · Completed
Enrollment 58 (actual)
Primary completion 2019-10-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
58 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2019-03-27
Primary completion
2019-10-30
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Sponsors
PRA Health SciencesCollaborator
Investigators
1
Ernest Roos, M.D.Study Director
Sites
1 total
Long Beach, United States
Facts & assertions
4 sourced
Enrollment
58
Phase
PHASE1
Primary Completion Date
2019-10-30
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator
person